The global LIMS market is expected to reach $1,323.6 million by 2019 from $848.5 million in 2014, growing at a CAGR of 9.3% from 2014 to 2019. Major factors contributing to the growth of the LIMS market include rising awareness on LIMS solutions through various conferences and forums, new product launches by prominent players, rise in the need to integrate healthcare systems, and rise in pressure to comply with regulatory requirements such as 21CFR part 11, HL7 (Health Level Seven International), HIPPA (Health Insurance Accountability and Portability Act), DICOM (Digital Imaging and Communications in Medicine),SOX (Sarbanes-Oxley Act),ISO (Indian Standard Organizations), FDA (Food and Drug Administration) CLIA (Clinical Laboratory Improvement Amendments), cGMP (Current Good Manufacturing Practices), cGLP (Current Good Laboratory Practices), NAMAS (Nationally Appropriate Mitigation Actions), UKAS (United Kingdom Accreditation Service),and NELAC (National Environment Accreditation Conference),amongst others. Relatively untapped markets of the Asian region, with an advent of increasing outsourcing activities of European and North American pharmaceutical companies in this region, have increased the demand for LIMS there. However, the high cost of maintenance and services of LIMS solutions and a lack of skilled HCIT professionals and are some factors that are expected to limit the growth of this market.